SNDX-5613-0707: Expanded Access Program for SNDX-5613 in Patients with Relapsed/Refractory Acute Leukemias with Genetic Alterations Associated with HOXA Overexpression

Primary Objective

The primary objective of this expanded access program (EAP) is to provide early access to treatment with SNDX-5613 in patients with R/R acute leukemias.

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Christine McMahon

Christine McMahon

Study ID

Protocol Number: 23-2063

More information available at ClinicalTrials.gov: NCT05918913

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers